What is the role of a target map during Hemodialysis (HD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Target MAP During Hemodialysis

The target mean arterial pressure (MAP) during hemodialysis should be maintained at approximately 65 mmHg or higher, with blood pressure goals of predialysis <140/90 mmHg and postdialysis <130/80 mmHg, prioritizing volume management through achievement of dry weight as the primary intervention before escalating antihypertensive medications. 1, 2

Primary Approach: Volume Management First

Volume control through ultrafiltration to achieve true dry weight must be the first-line strategy for blood pressure management during hemodialysis, not pharmacological intervention. 1, 2

  • Extracellular volume expansion is the primary driver of hypertension in hemodialysis patients, making dry weight achievement essential before considering medication adjustments 1
  • Gradual dry weight reduction (0.1 kg per 10 kg body weight) over 4-12 weeks reduces ambulatory blood pressure by approximately 7 mmHg while minimizing adverse events 1
  • Bioimpedance-guided fluid management can reduce fluid overload by 2.0 L and decrease systolic blood pressure by 25 mmHg without increasing intradialytic complications 3

Specific MAP Targets and Rationale

During hemodialysis sessions, maintain MAP ≥65 mmHg to ensure adequate tissue perfusion while avoiding the increased mortality associated with excessive hypotension. 1

  • Below MAP of 65 mmHg, tissue perfusion becomes linearly dependent on arterial pressure as autoregulation fails 1
  • Targeting MAP of 65 mmHg versus 85 mmHg shows no mortality difference but reduces arrhythmia risk and vasopressor requirements 1
  • Post-dialytic drops in systolic blood pressure up to 30 mmHg are associated with improved survival, but greater decreases correlate with higher mortality 1

Blood Pressure Measurement Technique

Measure blood pressure with the patient seated quietly for at least 5 minutes, feet on floor, arm supported at heart level, avoiding the access arm. 2

  • In patients with bilateral vascular access procedures, measure blood pressure in thighs or legs using appropriate cuff size in the supine position 2
  • Home or ambulatory blood pressure monitoring provides more accurate assessment than in-center measurements and should guide management decisions 2
  • Predialysis and postdialysis measurements alone correlate poorly with interdialytic ambulatory blood pressure and should not be the sole basis for treatment decisions 2

Ultrafiltration Rate Management

Limit ultrafiltration rate to prevent excessive intradialytic hypotension while achieving target fluid removal, typically keeping rates below 13 mL/kg/hour. 4

  • Excessive ultrafiltration rates increase intradialytic hypotension risk and are associated with increased mortality 4
  • For 2.5 L removal over 6 hours, the ultrafiltration rate of 417 mL/hour is generally well-tolerated 4
  • Monitor MAP every 30 minutes during sessions, particularly when initiating new ultrafiltration targets 4

Pharmacological Management When Volume Control Insufficient

If blood pressure remains elevated despite achieving dry weight, initiate ACE inhibitors or ARBs as first-line agents, administered preferentially at night to reduce nocturnal blood pressure surge. 2

  • ACE inhibitors and ARBs cause greater regression of left ventricular hypertrophy and may preserve residual kidney function 2
  • Beta-blockers are preferred in patients with coronary artery disease or heart failure 2
  • Consider medication dialyzability when selecting agents—highly dialyzable medications like metoprolol may have reduced efficacy during dialysis periods 2

Critical Pitfalls to Avoid

Do not initiate or escalate antihypertensive medications without first assessing and optimizing volume status, as this represents the most common error in hemodialysis blood pressure management. 2

  • Relying solely on predialysis or postdialysis measurements leads to inappropriate treatment decisions 2
  • A U-shaped relationship exists between blood pressure and mortality in dialysis patients—excessive reduction increases mortality risk 1, 2
  • Failing to account for the time-averaged fluid overload during the interdialytic period results in inadequate volume assessment 5

Sodium Management Strategy

Implement strict dietary sodium restriction (2-3 g/day) with regular dietitian counseling and consider lower dialysate sodium concentrations (135 mmol/L rather than 140 mmol/L). 2, 6

  • High dialysate sodium concentration and sodium profiling aggravate thirst, fluid gain, and hypertension 2
  • Sodium mass balance during hemodialysis directly impacts interdialytic fluid accumulation and blood pressure control 5

Special Populations

In elderly patients (>75 years), target MAP of 60-65 mmHg may reduce mortality compared to higher targets of 75-80 mmHg. 1

  • Patients with chronic hypertension may benefit from slightly higher MAP targets (up to 85 mmHg) to reduce need for renal replacement therapy 1
  • Monitor for orthostatic hypotension particularly in elderly patients when adjusting dry weight 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Pressure Management in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Guided optimization of fluid status in haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010

Guideline

Hemodialysis Parameters and Target Values

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sodium, volume and pressure control in haemodialysis patients for improved cardiovascular outcomes.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020

Guideline

Volume Assessment and Management in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.